KR100317426B1 - - Google Patents

Info

Publication number
KR100317426B1
KR100317426B1 KR940702316A KR940702316A KR100317426B1 KR 100317426 B1 KR100317426 B1 KR 100317426B1 KR 940702316 A KR940702316 A KR 940702316A KR 940702316 A KR940702316 A KR 940702316A KR 100317426 B1 KR100317426 B1 KR 100317426B1
Authority
KR
South Korea
Prior art keywords
pct
composition
sec
pharmaceutically acceptable
range
Prior art date
Application number
KR940702316A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Application granted granted Critical
Publication of KR100317426B1 publication Critical patent/KR100317426B1/ko

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465Nicotine; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0043Nose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34Tobacco-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36Opioid-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
KR940702316A 1992-01-03 1993-01-04 KR100317426B1 (ko)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929200047A GB9200047D0 (en) 1992-01-03 1992-01-03 Nicotine-containing nasal spray

Publications (1)

Publication Number Publication Date
KR100317426B1 true KR100317426B1 (ko) 2001-11-30

Family

ID=10708064

Family Applications (2)

Application Number Title Priority Date Filing Date
KR940702316A KR100317426B1 (ko) 1992-01-03 1993-01-04
KR1019940702316A KR950700055A (ko) 1992-01-03 1993-01-04 금연을 돕는 조성물(composition to help stop smoking)

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1019940702316A KR950700055A (ko) 1992-01-03 1993-01-04 금연을 돕는 조성물(composition to help stop smoking)

Country Status (21)

Country Link
US (1) US5656255A (ko)
EP (1) EP0619729B1 (ko)
JP (1) JP3830158B2 (ko)
KR (2) KR100317426B1 (ko)
AT (1) ATE182070T1 (ko)
AU (1) AU664415B2 (ko)
CA (1) CA2127253C (ko)
CZ (1) CZ294555B6 (ko)
DE (1) DE69325643T2 (ko)
DK (1) DK0619729T3 (ko)
ES (1) ES2135460T3 (ko)
FI (1) FI111049B (ko)
GB (1) GB9200047D0 (ko)
GR (1) GR3031075T3 (ko)
HU (1) HUT73247A (ko)
NO (1) NO308123B1 (ko)
NZ (1) NZ246533A (ko)
RU (1) RU2118897C1 (ko)
SK (1) SK282336B6 (ko)
UA (1) UA37201C2 (ko)
WO (1) WO1993012764A1 (ko)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9310412D0 (en) * 1993-05-20 1993-07-07 Danbiosyst Uk Nasal nicotine system
AUPM835394A0 (en) * 1994-09-23 1994-10-13 King, Michael G. Dr. Method for controlling or eliminating the need to smoke tobacco, and for treating ailments which may lead to the said need
JPH11507810A (ja) * 1995-06-05 1999-07-13 ヒューマン ジノーム サイエンシーズ,インコーポレイテッド Gタンパク質副甲状腺ホルモンレセプターhltdg74
CA2231968A1 (en) * 1998-03-11 1999-09-11 Smoke-Stop, A Partnership Consisting Of Art Slutsky Method of producing a nicotine medicament
GB9806937D0 (en) 1998-03-31 1998-05-27 Procter & Gamble A spray device
CA2359813C (en) * 2000-10-24 2008-04-22 Richard L. Jones Nicotine mucosal spray
US7458374B2 (en) 2002-05-13 2008-12-02 Alexza Pharmaceuticals, Inc. Method and apparatus for vaporizing a compound
US20030051728A1 (en) 2001-06-05 2003-03-20 Lloyd Peter M. Method and device for delivering a physiologically active compound
US20070122353A1 (en) 2001-05-24 2007-05-31 Hale Ron L Drug condensation aerosols and kits
US7645442B2 (en) 2001-05-24 2010-01-12 Alexza Pharmaceuticals, Inc. Rapid-heating drug delivery article and method of use
SE0102197D0 (sv) * 2001-06-20 2001-06-20 Pharmacia Ab New product and use and manufacture thereof
SE521512C2 (sv) 2001-06-25 2003-11-11 Niconovum Ab Anordning för administrering av en substans till främre delen av en individs munhåla
EP1304048B1 (en) * 2001-10-22 2004-09-22 Ivo Pera Composition to reduce or quit smoking addiction
SE0104388D0 (sv) * 2001-12-27 2001-12-27 Pharmacia Ab New formulation and use and manufacture thereof
US20030159702A1 (en) * 2002-01-21 2003-08-28 Lindell Katarina E.A. Formulation and use manufacture thereof
US20030171408A1 (en) * 2002-03-11 2003-09-11 Caplan Jay L. Therapeutic method of delivering a medicament to avoid irritating effects on membranes of user
SE0201669D0 (sv) * 2002-06-03 2002-06-03 Pharmacia Ab New formulation and use thereof
US7767698B2 (en) 2002-06-03 2010-08-03 Mcneil Ab Formulation and use thereof
US20040002520A1 (en) * 2002-07-01 2004-01-01 Soderlund Patrick L. Composition and method for cessation of Nicotine cravings
US20040105818A1 (en) 2002-11-26 2004-06-03 Alexza Molecular Delivery Corporation Diuretic aerosols and methods of making and using them
US7913688B2 (en) 2002-11-27 2011-03-29 Alexza Pharmaceuticals, Inc. Inhalation device for producing a drug aerosol
WO2004056363A2 (en) 2002-12-20 2004-07-08 Niconovum Ab A physically and chemically stable nicotine-containing particulate material
US20040234916A1 (en) 2003-05-21 2004-11-25 Alexza Molecular Delivery Corporation Optically ignited or electrically ignited self-contained heating unit and drug-supply unit employing same
US7540286B2 (en) 2004-06-03 2009-06-02 Alexza Pharmaceuticals, Inc. Multiple dose condensation aerosol devices and methods of forming condensation aerosols
JP5254616B2 (ja) 2004-09-13 2013-08-07 クロノ セラピューティクス、インコーポレイテッド 生物学的同調性(biosynchronous)経皮的薬物送達
US8252321B2 (en) 2004-09-13 2012-08-28 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
US7766018B2 (en) 2004-09-30 2010-08-03 Smoke-Break, Inc. Device and composition for reducing the incidence of tobacco smoking
US8322350B2 (en) * 2004-12-30 2012-12-04 Philip Morris Usa Inc. Aerosol generator
US8323683B2 (en) 2005-05-18 2012-12-04 Mcneil-Ppc, Inc. Flavoring of drug-containing chewing gums
CA2646942C (en) 2006-03-16 2014-07-29 Niconovum Ab Improved snuff composition
US20080216828A1 (en) 2007-03-09 2008-09-11 Alexza Pharmaceuticals, Inc. Heating unit for use in a drug delivery device
EP2322166A1 (en) * 2007-04-02 2011-05-18 Parkinson's Institute Methods and compositions for reduction of side effects of therapeutic treatments
CN101883833B (zh) * 2007-11-30 2014-02-26 日本烟草产业株式会社 气溶胶抽吸器用气溶胶产生液
EP2233134A1 (en) 2009-03-27 2010-09-29 McNeil AB Multi-portion intra-oral dosage form with organoleptic properties
WO2011087393A1 (ru) * 2010-01-18 2011-07-21 Общество С Ограниченной Ответственностью "Вегавольт" Композиция растительного происхождения, предназначенная для вдыхания дыма, образующегося при ее сжигании
US20110268809A1 (en) 2010-04-28 2011-11-03 Paul Andrew Brinkley Nicotine-Containing Pharmaceutical Compositions
US20110274628A1 (en) 2010-05-07 2011-11-10 Borschke August J Nicotine-containing pharmaceutical compositions
US20130017259A1 (en) 2011-07-06 2013-01-17 The Parkinson's Institute Compositions and Methods for Treatment of Symptoms in Parkinson's Disease Patients
US20130078307A1 (en) 2011-09-22 2013-03-28 Niconovum Usa, Inc. Nicotine-containing pharmaceutical composition
US9907748B2 (en) 2011-10-21 2018-03-06 Niconovum Usa, Inc. Excipients for nicotine-containing therapeutic compositions
CA2974324A1 (en) 2015-01-28 2016-08-04 Zita S. Netzel Drug delivery methods and systems
WO2016145373A1 (en) 2015-03-12 2016-09-15 Chrono Therapeutics Inc. Craving input and support system
US10532046B2 (en) 2015-12-03 2020-01-14 Niconovum Usa, Inc. Multi-phase delivery compositions and products incorporating such compositions
US20170165252A1 (en) 2015-12-10 2017-06-15 Niconovum Usa Inc. Protein-enriched therapeutic composition
CN109069497A (zh) * 2016-02-29 2018-12-21 尼古珍有限公司 尼古丁制剂和气雾剂
AU2018205529B2 (en) 2017-01-06 2023-08-10 Morningside Venture Investments Limited Transdermal drug delivery devices and methods
SE541358C2 (en) 2017-05-30 2019-08-13 Enorama Pharma Ab Nicotine-containing chewing gum compositions
JP7420797B2 (ja) 2018-05-29 2024-01-23 モーニングサイド ベンチャー インベストメンツ リミテッド 薬剤送達の方法及びシステム
CN112384504A (zh) 2018-06-15 2021-02-19 R.J.雷诺兹烟草公司 烟碱的纯化
CZ309558B6 (cs) * 2021-05-25 2023-04-12 Consumer Brands International s.r.o. Náplň nikotinového prostředku, zejména nikotinového sáčku a způsob jeho výroby

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4953572A (en) * 1985-04-25 1990-09-04 Rose Jed E Method and apparatus for aiding in the reduction of incidence of tobacco smoking

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2030862A (en) * 1978-04-10 1980-04-16 Smith A A composition for treating drug addiction such as smoking nicotine-containing products
DE3241437A1 (de) * 1982-11-10 1984-05-10 Ferdinand Prof. Dr.med. 6901 Wilhelmsfeld Schmidt Mittel zum zwecke der raucherentwoehnung und/oder fuer nebenwirkungsfreien nikotingenuss bei suchtrauchern
GB8301659D0 (en) * 1983-01-21 1983-02-23 Leo Ab Smoking substitutes
GB2133691B (en) * 1983-01-21 1986-05-21 Leo Ab Smoking substitutes for nasal administration
US4920989A (en) * 1985-04-25 1990-05-01 Regents Of The University Of California Method and apparatus for aiding in the reduction of incidence of tobacco smoking
US4715387A (en) * 1985-08-23 1987-12-29 The Regents Of The Univ. Of California Aerosol for use in the reduction of tobacco smoking
SE8601351D0 (sv) * 1986-03-24 1986-03-24 Nilsson Sven Erik Styrd administration av fysiologiskt aktiva emnen
GB8614805D0 (en) * 1986-06-18 1986-07-23 British American Tobacco Co Aerosol device

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4953572A (en) * 1985-04-25 1990-09-04 Rose Jed E Method and apparatus for aiding in the reduction of incidence of tobacco smoking

Also Published As

Publication number Publication date
NO942502L (no) 1994-09-02
ES2135460T3 (es) 1999-11-01
GR3031075T3 (en) 1999-12-31
UA37201C2 (uk) 2001-05-15
JP3830158B2 (ja) 2006-10-04
RU2118897C1 (ru) 1998-09-20
FI943173A (fi) 1994-09-01
EP0619729A1 (en) 1994-10-19
NZ246533A (en) 1996-04-26
CZ294555B6 (cs) 2005-02-16
FI943173A0 (fi) 1994-07-01
CA2127253C (en) 1999-09-21
JPH07504164A (ja) 1995-05-11
RU94040387A (ru) 1996-10-20
CA2127253A1 (en) 1993-07-08
GB9200047D0 (en) 1992-02-26
CZ160894A3 (en) 1995-09-13
DK0619729T3 (da) 2000-04-17
NO308123B1 (no) 2000-07-31
SK282336B6 (sk) 2002-01-07
KR950700055A (ko) 1995-01-16
US5656255A (en) 1997-08-12
EP0619729B1 (en) 1999-07-14
DE69325643T2 (de) 2000-02-10
ATE182070T1 (de) 1999-07-15
WO1993012764A1 (en) 1993-07-08
SK79694A3 (en) 1995-06-07
HUT73247A (en) 1996-07-29
HU9402003D0 (en) 1994-09-28
FI111049B (fi) 2003-05-30
DE69325643D1 (de) 1999-08-19
AU664415B2 (en) 1995-11-16
NO942502D0 (no) 1994-07-01
AU3340393A (en) 1993-07-28

Similar Documents

Publication Publication Date Title
KR100317426B1 (ko)
US5783207A (en) Selectively removable nicotine-containing dosage form for use in the transmucosal delivery of nicotine
US5810018A (en) Method, composition and apparatus for reducing the incidence of cigarette smoking
CA2359813A1 (en) Nicotine mucosal spray
HK12495A (en) Pharmaceutical formulations
GR3022527T3 (en) Pharmaceutical inhalation compositions.
JPH072654A (ja) 吸入によるタウリン投与装置
IL147876A0 (en) Use of agonists of gabab receptors and pharmaceutically acceptable derivatives thereof, in the therapy of maintaining nicotine abstinence-dependent patients
WO1996000071A1 (en) Treatment of nicotine craving and/or smoking withdrawal symptoms with a liquid nasal composition containing nicotine and caffeine or xanthine
PL297882A1 (en) Agent facilitating to lose the habit of cigarette smoking
Hendrie Alternative strategies and new treatments for smoking